Role of a Biomedical Engineer in Latin America as a Supplier of Medical Devices and Services for an Asian Transnational Company

Main Article Content

Daniel Ricardo Argumedo https://orcid.org/0000-0002-1544-4865

Keywords

Biomedical engineer, Multinational , Technical service, Marketing, Business

Abstract

The hiring of biomedical engineers by an Asian multinational in Latin America is increasing. Chinese companies are expanding, and this professional profile is the most sought-after saliency by these companies. Biomedical engineers have multidisciplinary training to support multinationals in planning, finding potential distributors, and performing pre-sales and post-sales operations, thereby involving biomedical engineer in all company departments. Biomedical engineers are key and highly valuable employees for the business growth of companies in Latin America. This paper provides biomedical engineers an overview of the activities performed by a Chinese multinational, the challenges, important peculiarities of Latin American countries, and the skills and capabilities that a biomedical engineer must have to work for a Chinese multinational.

Downloads

Download data is not yet available.

Abstract 77 | PDF Downloads 31

References

1. Wise, C.. The past, present, and future of China–Latin America relations. Oxford Research Encyclopedia of International Studies. Oxford University Press: Oxford, UK; 2023. https://doi.org/10.1093/acrefore/9780190846626.013.736..
2. Rao, K.D., Vecino Ortiz, A.I., Roberton, T., et al. Future health spending in Latin America and the Caribbean: health expenditure projections & scenario analysis. Inter-American Development Bank. 2022. https://doi.org/10.18235/0004185.
3. Zamhuri, A., Lim, G.P., Ma, N.L. et al. MXene in the lens of biomedical engineering: synthesis, applications and future outlook. BioMed Eng OnLine. 2021;20:33. https://doi.org/10.1186/s12938-021-00873-9.
4. Zámborský, P., Yan, Z.J., Michailova, S., et al. Chinese multinationals’ internationalization strategies: new realities, new pathways. Calif Manag Rev. 2023;66(1):96–123. https://doi.org/10.1177/00081256231193467.
5. Sun, J., Pan, J. Jin, Y., et al. Establishment of a medical device adverse event management system for hospitals. BMC Health Ser Res. 2022;22(1):1406. https://doi.org/10.1186/s12913-022-08830-5.
6. Madihally, S. Principles of Biomedical Engineering. Artech House: Norwood, MA; 2019.
7. Máttar, J, Riffo, L. Territorial development in Latin America: a long-term perspective. In Regional Problems and Policies in Latin America; Cuadrado-Roura, J.R., Aroca, P., eds. Springer: Berlin, Germany; 2013, pp. 43–68. https://doi.org/10.1007/978-3-642-39674-8_3.
8. Fazekas, M., Borges de Oliveira, A., Regös, N. Lowering prices of pharmaceuticals, medical supplies, and equipment. 2021. Available online: https://openknowledge.worldbank.org/server/api/core/bitstreams/5db42514-8219-5137-9745-021853fdce2d/content.
9. Brea, Jorge A. Population dynamics in Latin America. Popul Bull. 2003;58(1):3–36. Available online: https://www.prb.org/resource/population-dynamics-in-latin-america/.
10. Galindo, A., Izquierdo, A. Latin American and Caribbean Macroeconomic Report: Ready for Take-Off? Building on Macroeconomic Stability for Growth. IDB Series, Annual Reports. IDB: Washington, DC; 2024. https://doi.org/10.18235/0005667.
11. Matus-López, M., Pérez, P.F. Transformations in Latin American healthcare: a retrospective analysis of hospital beds, medical doctors, and nurses from 1960 to 2022. J Evol Stud Bus. 2023;8(2):248–288. https://doi.org/10.1344/jesb2023.8.2.42709.
12. Popp, W., Rasslan, O., Unahalekhaka, A., et al. What is the use? An international look at reuse of single-use medical devices. Int J Hygiene Environ Health. 2010;213(4):302–307. https://doi.org/10.1016/j.ijheh.2010.04.003.
13. Cera, C., Servia, G. Medical device regulatory affairs in Latin America. In: Medical Regulatory Affairs. Jenny Stanford Publishing: United Square, Singapore; 2022, pp. 335–362. https://doi.org/10.1201/9781003207696-26.
14. Guo, J. The political economy of China–Latin America relations: the making of a post-boom paradigm. China Int Strat Rev. 2023;5(1):113–138. https://doi.org/10.1007/s42533-023-00126-5.
15. da Fonseca, L.S.P. O processo de regularização de dispositivos médicos no Brasil. Manual de Tecnovigilância: Uma abordagem sob a ótica da Vigilância Sanitária: 409. Abailable online: https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/publicacoes/MANUALTECNOVIGILANCIA2021v43.pdf.
16. De Souza, B.J.C., et al. Compilation about adverse events recorded in FDA/USA and ANVISA/Brazil databases through models available in the literature concerning analysis and prioritization of actions for medical devices. Glob Clin Eng J. 2021;4(2):5–14. https://doi.org/10.31354/globalce.v4i2.121.
17. Ceppi, N, Doval, G.P. Brazil-China bilateral link during the 21st century: business as usual. Janus.Net. 2024;15(2):TD1. https://doi.org/10.26619/1647-7251.DT0324.9.
18. de la Torre Medina, M. Chinese trade bilateralism and Latin America: the case of China-Chile free trade agreement. México y la cuenca del Pacífico (México Pacific Basin). 2020;9(27):109–128. https://doi.org/10.32870/mycp.v9i27.687.
19. Gettig, F.S., Romero, N.E., Riffel, S.G., et al. Medical Devices Post Market Monitoring: In Comas, D.S., Meschino, G.J., Pérez-Buitrago, S.M., et al., eds. In Advances in Bioengineering and Clinical Engineering 2025, Proceedings of the XXV Argentinian Congress of Bioengineering (SABI 2025), the XIV Clinical Engineering Conference, and the III Latin American Conference on Clinical Engineering (CLIC), Mar del Plata, Argentina. October 14–17,2025:528–536. IFMBE Proceedings, vol 136. Springer, Cham. https://doi.org/10.1007/978-3-032-06401-1_46.
20. Kirubakaran N., Rani, K.R.V., Srinivasan.U.M., et al. Pharmaceutical drugs, biologics, gene therapies, and medical device regulation. In Artificial Intelligence in Pharmaceutical Sciences; Bhupathyraaj, M., Vijaya Rani, R., Essa, M.M. CRC Press: New York, NY; 2023, pp. 117–129. https://doi.org/10.1201/9781003343981-8.
21. Long, T., Urdinez, F. Status at the margins: why Paraguay recognizes Taiwan and Shuns China. Foreign Policy Anal. 2021;17(1):oraa002. https://doi.org/10.1093/fpa/oraa002.
22. Galvan, P. Clinical engineering in Paraguay. In Clinical Engineering Handbook, 2nd ed.; Iadanza, E., ed. Academic Press: Cambridge, MA; 2020, pp. 87–93. https://doi.org/10.1016/B978-0-12-813467-2.00011-0.
23. Gutiérrez, J,E,V. Clinical engineering in Colombia. In Clinical Engineering Handbook, 2nd ed.; Iadanza, E., ed. Academic Press: Cambridge, MA; 2020, pp. 75–81. https://doi.org/10.1016/B978-0-12-813467-2.00009-2.